Search - tctmd.com

Displaying 521 - 540 of 549

Sort: Relevancy | Date

Presentation

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

Presenter: T. Palmerini

June 04, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Conference News EuroPCR 2013

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Caitlin E. Cox

May 23, 2013

News Daily News

Longer Ischemic Times in Women with STEMI Due to Age, Comorbidities

Yael L. Maxwell

December 05, 2012

News Daily News

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

September 19, 2012

News Daily News

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

September 19, 2012

Presentation

Unrestricted Use of 2 New-Generation DES in Pts with AMI

Presenter: K-Y Chen

September 18, 2012

Presentation

Stent for Life: Optimizing Primary Percutaneous Coronary Intervention in Europe

Presenter: 46672|Steen Dalby Kristensen

August 26, 2012

News Conference News ESC 2012

Survey Reveals Improvements, Gaps in Primary PCI Access Across Europe

Jason Kahn

August 26, 2012

Presentation ACVS 2012

BMS vs DES in AMI

Presenter: Manish Parikh

August 04, 2012

News Daily News

Xience V Noninferior to Cypher for Primary PCI

July 24, 2012

News Daily News

El Xience V No es Inferior al Cypher en PCI Primarias

July 24, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

Presentation EuroPCR 2012

APPOSITION III: Evaluation of the STENTYS self-apposing bare and drug-eluting stent in 1000 STEMI patients in a real-life setting: in-hospital and 30-day outcomes

Presenter: 166648|giovanni amoroso

May 18, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

News Daily News

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

L.A. McKeown

April 25, 2012

News Daily News

Meta Análisis: Los SLF de 1ª Generación se Muestran Seguros y Eficaces a Largo Plazo contra los STEMI

L.A. McKeown

April 25, 2012

Presentation

DES vs. BMS in Primary Angioplasty: Pooled Patient-Level Meta-Analysis of Randomized Trials

Presenter: Giuseppe De Luca

April 24, 2012

Presentation

Comparison of DES with BMS in Patients with STEMI

Presenter: B. Kalesan

February 27, 2012

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

Advertisement

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Longer Ischemic Times in Women with STEMI Due to Age, Comorbidities

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

Unrestricted Use of 2 New-Generation DES in Pts with AMI

Stent for Life: Optimizing Primary Percutaneous Coronary Intervention in Europe

Survey Reveals Improvements, Gaps in Primary PCI Access Across Europe

BMS vs DES in AMI

Xience V Noninferior to Cypher for Primary PCI

El Xience V No es Inferior al Cypher en PCI Primarias

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

APPOSITION III: Evaluation of the STENTYS self-apposing bare and drug-eluting stent in 1000 STEMI patients in a real-life setting: in-hospital and 30-day outcomes

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

Meta Análisis: Los SLF de 1ª Generación se Muestran Seguros y Eficaces a Largo Plazo contra los STEMI

DES vs. BMS in Primary Angioplasty: Pooled Patient-Level Meta-Analysis of Randomized Trials

Comparison of DES with BMS in Patients with STEMI

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content